tirzepatide and heart Effects of tirzepatide, a dual GIP GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Mounjaro, Zepbound Lowers Risk of

doi: 10.3389/fcimb.2023.1268016 Received 27 July 2023 Accepted 09 November 2023 Published 21 December 2023 Volume 13 - 2023 Edited by Vishwanath Venketaraman, Western University of Health Sciences, United States Reviewed by Heidi N

For people with fatty liver disease who also need weight management, survodutide could emerge as the preferred option once approved

Risk of Malignant neoplasia with glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes: A meta-analysis

This 'smart regulation' helps explain why GHK-Cu improves scar quality

Samajdar SS et al

Your condition will not improve any faster, and your risk of side effects will increase